Novavax submits variations to expand approval in Australia and New Zealand for adolescents
If granted, Nuvaxovid would be the first protein-based Covid-19 vaccine option for adolescents in Australia and New Zealand
If granted, Nuvaxovid would be the first protein-based Covid-19 vaccine option for adolescents in Australia and New Zealand
The FDA has determined that the known and potential benefits of the vaccine for the prevention of Covid-19 outweigh the known and potential risks for individuals 18 years of age and older for whom other authorized or approved vaccines are not accessible
While Pregabalin will be manufactured at the Aurangabad facility, Iloperidone will be manufactured at the Goa facility
Ranked 25th with an impressive growth rate of 29% among Indian pharma companies in FY 2021-22
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
An Integrated programme comprising GOQii device, Glucometer – Contour Plus+1 from Ascensia Diabetes Care India and personalised diabetes coaching
The facility is among 12 centres established worldwide, and the first in Asia
He will be leading the business, operations, P&L, and growth strategy for StanPlus
The USFDA approval in AS marks the fifth indication for Rinvoq in chronic immune-mediated diseases
The management believes that its strong product pipeline, diversified innovative product portfolio, continued expansion into new geographies and FGMP accreditations will help sustain the growth momentum in the coming few years
Subscribe To Our Newsletter & Stay Updated